These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2587437)

  • 1. The central action of 1-(2-pyrimidinyl)-piperazine, an ipsapirone metabolite.
    Tatarczyńska E; Pawłowski L; Chojnacka-Wójcik E; Maj J
    Pol J Pharmacol Pharm; 1989; 41(1):51-61. PubMed ID: 2587437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central beta- and alpha-adrenolytic activities of adimolol.
    Maj J; Klimek V; Lewandowska A; Zazula M
    Pol J Pharmacol Pharm; 1987; 39(1):81-90. PubMed ID: 2890141
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central antiserotonergic and antidopaminergic action of pirenperone, a putative 5-HT2 receptor antagonist.
    Pawłowski L; Siwanowicz J; Bigajska K; Przegaliński E
    Pol J Pharmacol Pharm; 1985; 37(2):179-96. PubMed ID: 4048012
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ipsapirone and 1-(2-pyrimidinyl)-piperazine increase rat locus coeruleus noradrenergic activity.
    Sanghera MK; Coke JA; Williams HL; McMillen BA
    Brain Res Bull; 1990 Jan; 24(1):17-22. PubMed ID: 2310943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central action of ipsapirone, a new anxiolytic drug, on serotoninergic, noradrenergic and dopaminergic functions.
    Maj J; Chojnacka-Wójcik E; Tatarczyńska E; Kłodzińska A
    J Neural Transm; 1987; 70(1-2):1-17. PubMed ID: 2889795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The central action of carbamazepine as a potential antidepressant drug.
    Maj J; Chojnacka-Wójcik E; Lewandowska A; Tatarczyńska E; Wiczyńska B
    Pol J Pharmacol Pharm; 1985; 37(1):47-56. PubMed ID: 4041037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tandospirone and its metabolite, 1-(2-pyrimidinyl)-piperazine--II. Effects of acute administration of 1-PP and long-term administration of tandospirone on noradrenergic neurotransmission.
    Blier P; Curet O; Chaput Y; de Montigny C
    Neuropharmacology; 1991 Jul; 30(7):691-701. PubMed ID: 1681447
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant activities of WEB 1881, a new nootropic agent.
    Maj J; Rogóz Z; Skuza G; Sowińska H; Nowak G
    Pol J Pharmacol Pharm; 1989; 41(5):439-52. PubMed ID: 2561889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central action of pirenzepine.
    Rogóz Z; Skuza G; Sowińska H
    Pol J Pharmacol Pharm; 1981; 33(6):615-26. PubMed ID: 6897118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A serotonergic component in the central action of 1-(o-methoxyphenyl)-piperazine.
    Pawłowski L
    Pol J Pharmacol Pharm; 1983; 35(4):319-26. PubMed ID: 6664937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Central serotoninmimetic action of phenylpiperazines.
    Maj J; Lewandowska A
    Pol J Pharmacol Pharm; 1980; 32(4):495-504. PubMed ID: 7255267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of the alpha 2-adrenoceptor blocking properties of buspirone and ipsapirone in healthy subjects. Relationship with the plasma concentration of the common metabolite 1-(2-pyrimidinyl)-piperazine.
    Berlin I; Chalon S; Payan C; Schöllnhammer G; Cesselin F; Varoquaux O; Puech AJ
    Br J Clin Pharmacol; 1995 Mar; 39(3):243-9. PubMed ID: 7619663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The alpha 2-adrenoceptor antagonist activity of ipsapirone and gepirone is mediated by their common metabolite 1-(2-pyrimidinyl)-piperazine (PmP).
    Bianchi G; Caccia S; Della Vedova F; Garattini S
    Eur J Pharmacol; 1988 Jul; 151(3):365-71. PubMed ID: 2905658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats.
    Zuideveld KP; Rusiç-Pavletiç J; Maas HJ; Peletier LA; Van der Graaf PH; Danhof M
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1130-7. PubMed ID: 12438536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral buspirone causes a shift in the dose-response curve between the elevated-plus maze and Vogel conflict tests in Long-Evans rats: relation of brain levels of buspirone and 1-PP to anxiolytic action.
    Vaidya AH; Rosenthal DI; Lang W; Crooke JJ; Benjamin D; Ilyin SE; Reitz AB
    Methods Find Exp Clin Pharmacol; 2005 May; 27(4):245-55. PubMed ID: 16082425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the effects of some 5-HT1A receptor agonists on the blood pressure of pithed rats.
    Castillo C; Bobadilla RA; Ibarra M; Castillo EF; Hong E
    Arch Med Res; 1995; 26(3):251-5. PubMed ID: 8580676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychopharmacological profile of dexamisole.
    Przegaliński E; Bigajska K; Siwanowicz J
    Pol J Pharmacol Pharm; 1980; 32(1):21-9. PubMed ID: 7454609
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Central action of adrenaline.
    Jagiełło-Wójtowicz E
    Acta Physiol Pol; 1981; 32(2):169-80. PubMed ID: 7196677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The central action of salbutamol, a beta-agonist with a potential antidepressant activity.
    Przegalinski E; Baran L; Kedrek G
    Pol J Pharmacol Pharm; 1980; 32(4):485-93. PubMed ID: 6265886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Kinetics, brain uptake, and receptor binding of tandospirone and its metabolite 1-(2-pyrimidinyl)-piperazine.
    Miller LG; Thompson ML; Byrnes JJ; Greenblatt DJ; Shemer A
    J Clin Psychopharmacol; 1992 Oct; 12(5):341-5. PubMed ID: 1362206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.